Excimer laser treatment for ametropia Eye Diseases Excimer laser treatment for ametropia
Conditions
Interventions
Potentially eligible participants treated at the refractive centre of the cantonal hospital Lucerne (LUKS) are informed about the existence of the study by their treating ophthalmologist. During an in
Sponsors
Augenklinik Luzerner Kantonsspital [Cantonal Hospital Lucerne Eye Clinic]
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients assessing refractive excimer laser therapy for ametropia at the refractive centre of the LUKS will be evaluated at their initial visit for study inclusion 2. Signed written informed consent form
Exclusion criteria
Exclusion criteria: 1. Inability to follow the procedures of the study due to i.e. language problems, psychological disorders, dementia etc 2. Aged < 18 years 3. Enrolment of the investigator, his/her family members, employees and other dependent persons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients knowledge is measured using five multiple choice questions with five statements after the consultation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patients’ satisfaction is measured using a questionnaire after the consultation. 2. Anxiety levels is measured using a subpart of the State-Trait Anxiety Inventory 42 after the consultation. 3. Perceived contact time measured using a questionnaire after the consultation. | — |
Countries
Switzerland
Outcome results
None listed